Makes medicines from donated blood plasma to help fight infections.
Bought more
Duquesne owns 2.8 million shares of ADMA Biologics, worth about $23 million. That’s less than $1 of every $100 they have in stocks. Between April and June they bought 1.2 million more (up 80%).
Mar 31
1,545,610
Jun 30
2,784,110
The numbers
Shares they own
2,784,110
Change since Mar 31
+1,238,500
+80.1%
Shares on Mar 31
1,545,610
Value on Jun 30, 2026
$23,303,000
about $23 million
Share of their money
0.5%
less than $1 of every $100 · 35th of 85
Price per share on Jun 30
$8.37
Cost of the shares they added
about $10 million
at the Jun 30 price
Kind
Shares
More about ADMA Biologics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.